Total: 10 projects
Interventional Nephrology—Endovascular salvage of AVF 2001-Present (see related abstracts).
Interventional Nephrology—Thrombectomy of dialysis access 2001-Present.
Interventional Nephrology—Endovascular stents for AC access salvage 2005-Present (see related abstracts).
Pharmaceutical Company Sponsored Multi-center Trials 2001-Present -Use of erythropoeisis stimulating agents in Anemia in Chronic Kidney Disease.
“Roche” Multicenter Trials on erythropoeitic agents in anemia 2003-Present.
-Principal Investigator: Salvage of dialysis AV access by endovascular stents Investigator initiated research (2005-Present).
-Principal Investigator: An Open-Label, Randomized, Multi-center, Parallel Group Study to Demonstrate Correction of Anemia Using Subcutaneous Injections of RO0503821 (Continuous Erythropoietin Receptor Activator) in Patients with Chronic Kidney disease who are not on dialysis. (2004-Present)
-Principal Investigator: A Randomized, Controlled, Open-label, Multi-center, Parallel-Group Study To Demonstrate The Efficacy and Safety of RO0503821 (Continuous Erythropoietin Receptor Activator) When Administered Intravenously For the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are On Dialysis (1/2004-present).
-Co-investigator: The value of peak 2-Hr blood cyclosporine levels (C2) in the management of kidney transplant recipients. Investigator-Initiated Research project and funded by Novartis (2003-present).
-Co-investigator: Efficacy and safety of mechanical thrombectomy of dialysis PTFE grafts. Investigator initiated research (1998-present).